ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC

Luke H. Stockwin(Science Applications International Corporation (United States)), Dianne L. Newton(Science Applications International Corporation (United States))
BMC Cancer
February 20, 2009
10.1186/1471-2407-9-63
Cited by 28

Related Papers

Oxyphenisatin acetate (<scp>NSC</scp>59687) triggers a cell starvation response leading to autophagy, mitochondrial dysfunction, and autocrine<scp>TNF</scp>α‐mediated apoptosis
|Cancer Medicine|2013|17
UNC2025 , a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor
|Figshare|2020|7